ReP USP - Resultado da busca

Artigo de periodico
Easy obtainment and biological applicability of pinocarvyl acetate by encapsulating of the Microlicia graveolens essential oil in oil-in-water nanoemulsions (2025)
Seibert, Janaína Brandão ; Amparo, Tatiane Roquete ; Sousa, Lucas Resende Dutra; Rodrigues, Ivanildes Vasconcelos ; Petit, Alicia; Pervier, Pauline; Azevedo, Mariana Costa; Sales Junior, Policarpo Ademar ; Murta, Silvane Maria Fonseca; Carneiro, Cláudia Martins ; Teixeira, Luiz Fernando de Medeiros; Souza, Gustavo Henrique Bianco de; Vieira, Paula Melo de Abreu ; Santos, Orlando David Henrique dos
Source: Pharmaceutics. Unidade: ESALQ
Subjects: ÓLEOS ESSENCIAIS, PLANTAS NATIVAS, CETONA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SEIBERT, Janaína Brandão et al. Easy obtainment and biological applicability of pinocarvyl acetate by encapsulating of the Microlicia graveolens essential oil in oil-in-water nanoemulsions. Pharmaceutics, v. 17, p. 1-16, 2025Tradução . . Disponível em: https://doi.org/10.3390/pharmaceutics17091130. Acesso em: 08 out. 2025.
APA
Seibert, J. B., Amparo, T. R., Sousa, L. R. D., Rodrigues, I. V., Petit, A., Pervier, P., et al. (2025). Easy obtainment and biological applicability of pinocarvyl acetate by encapsulating of the Microlicia graveolens essential oil in oil-in-water nanoemulsions. Pharmaceutics, 17, 1-16. doi:10.3390/pharmaceutics17091130
NLM
Seibert JB, Amparo TR, Sousa LRD, Rodrigues IV, Petit A, Pervier P, Azevedo MC, Sales Junior PA, Murta SMF, Carneiro CM, Teixeira LF de M, Souza GHB de, Vieira PM de A, Santos ODH dos. Easy obtainment and biological applicability of pinocarvyl acetate by encapsulating of the Microlicia graveolens essential oil in oil-in-water nanoemulsions [Internet]. Pharmaceutics. 2025 ; 17 1-16.[citado 2025 out. 08 ] Available from: https://doi.org/10.3390/pharmaceutics17091130
Vancouver
Seibert JB, Amparo TR, Sousa LRD, Rodrigues IV, Petit A, Pervier P, Azevedo MC, Sales Junior PA, Murta SMF, Carneiro CM, Teixeira LF de M, Souza GHB de, Vieira PM de A, Santos ODH dos. Easy obtainment and biological applicability of pinocarvyl acetate by encapsulating of the Microlicia graveolens essential oil in oil-in-water nanoemulsions [Internet]. Pharmaceutics. 2025 ; 17 1-16.[citado 2025 out. 08 ] Available from: https://doi.org/10.3390/pharmaceutics17091130
Artigo de periodico
A new heteroleptic Zn(II) complex with Schiff bases sensitizes triple-negative breast cancer cells to Doxorubicin and Paclitaxel (2024)
Machado, Raiane Aparecida dos Santos; Siqueira, Raoni Pais; Silva, Fernanda Cardoso da; Matos, André Carlos Pereira de; Borges, Dayanne Silva; Rocha, Gislaine Gonçalves; Souza, Thais Cristina Prado de; Souza, Rafael Aparecido Carvalho; Oliveira, Clayton Rodrigues de; Ferreira, Antônio Gilberto ; Maia, Pedro Ivo da Silva ; Deflon, Victor Marcelo ; Oliveira, Carolina Gonçalves; Araújo, Thaise Gonçalves
Source: Pharmaceutics. Unidade: IQSC
Subjects: NEOPLASIAS, QUIMIOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MACHADO, Raiane Aparecida dos Santos et al. A new heteroleptic Zn(II) complex with Schiff bases sensitizes triple-negative breast cancer cells to Doxorubicin and Paclitaxel. Pharmaceutics, v. 16, p. 1610, 2024Tradução . . Disponível em: https://doi.org/10.3390/ pharmaceutics16121610. Acesso em: 08 out. 2025.
APA
Machado, R. A. dos S., Siqueira, R. P., Silva, F. C. da, Matos, A. C. P. de, Borges, D. S., Rocha, G. G., et al. (2024). A new heteroleptic Zn(II) complex with Schiff bases sensitizes triple-negative breast cancer cells to Doxorubicin and Paclitaxel. Pharmaceutics, 16, 1610. doi:10.3390/ pharmaceutics16121610
NLM
Machado RA dos S, Siqueira RP, Silva FC da, Matos ACP de, Borges DS, Rocha GG, Souza TCP de, Souza RAC, Oliveira CR de, Ferreira AG, Maia PI da S, Deflon VM, Oliveira CG, Araújo TG. A new heteroleptic Zn(II) complex with Schiff bases sensitizes triple-negative breast cancer cells to Doxorubicin and Paclitaxel [Internet]. Pharmaceutics. 2024 ;16 1610.[citado 2025 out. 08 ] Available from: https://doi.org/10.3390/ pharmaceutics16121610
Vancouver
Machado RA dos S, Siqueira RP, Silva FC da, Matos ACP de, Borges DS, Rocha GG, Souza TCP de, Souza RAC, Oliveira CR de, Ferreira AG, Maia PI da S, Deflon VM, Oliveira CG, Araújo TG. A new heteroleptic Zn(II) complex with Schiff bases sensitizes triple-negative breast cancer cells to Doxorubicin and Paclitaxel [Internet]. Pharmaceutics. 2024 ;16 1610.[citado 2025 out. 08 ] Available from: https://doi.org/10.3390/ pharmaceutics16121610
Artigo de periodico
Protium spruceanum extract enhances mupirocin activity when combined with nanoemulsion-based hydrogel: A multi-target strategy for treating skin and soft tissue infections (2024)
Amparo, Tatiane Roquete ; Sousa, Lucas Resende Dutra ; Xavier, Viviane Flores; Seibert, Janaína Brandão ; Paiva, Débora Luiza; Silva, Débora dos Santos da; Teixeira, Luiz Fernando de Medeiros; Santos, Orlando David Henrique dos ; Vieira, Paula Melo de Abreu ; Souza, Gustavo Henrique Bianco de; Brandão, Geraldo Célio
Source: Pharmaceutics. Unidade: ESALQ
Subjects: AGENTES ANTIMICROBIANOS, ANTIBIÓTICOS, DOENÇAS DA PELE E DO TECIDO CONJUNTIVO, FÁRMACOS DE ORIGEM VEGETAL, PRODUTOS NATURAIS, SINERGISMO DE DROGAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AMPARO, Tatiane Roquete et al. Protium spruceanum extract enhances mupirocin activity when combined with nanoemulsion-based hydrogel: A multi-target strategy for treating skin and soft tissue infections. Pharmaceutics, v. 16, p. 1-18, 2024Tradução . . Disponível em: https://doi.org/10.3390/pharmaceutics16060700. Acesso em: 08 out. 2025.
APA
Amparo, T. R., Sousa, L. R. D., Xavier, V. F., Seibert, J. B., Paiva, D. L., Silva, D. dos S. da, et al. (2024). Protium spruceanum extract enhances mupirocin activity when combined with nanoemulsion-based hydrogel: A multi-target strategy for treating skin and soft tissue infections. Pharmaceutics, 16, 1-18. doi:10.3390/pharmaceutics16060700
NLM
Amparo TR, Sousa LRD, Xavier VF, Seibert JB, Paiva DL, Silva D dos S da, Teixeira LF de M, Santos ODH dos, Vieira PM de A, Souza GHB de, Brandão GC. Protium spruceanum extract enhances mupirocin activity when combined with nanoemulsion-based hydrogel: A multi-target strategy for treating skin and soft tissue infections [Internet]. Pharmaceutics. 2024 ; 16 1-18.[citado 2025 out. 08 ] Available from: https://doi.org/10.3390/pharmaceutics16060700
Vancouver
Amparo TR, Sousa LRD, Xavier VF, Seibert JB, Paiva DL, Silva D dos S da, Teixeira LF de M, Santos ODH dos, Vieira PM de A, Souza GHB de, Brandão GC. Protium spruceanum extract enhances mupirocin activity when combined with nanoemulsion-based hydrogel: A multi-target strategy for treating skin and soft tissue infections [Internet]. Pharmaceutics. 2024 ; 16 1-18.[citado 2025 out. 08 ] Available from: https://doi.org/10.3390/pharmaceutics16060700
Artigo de periodico
Gold(I) and Silver(I) Complexes Containing Hybrid Sulfonamide/Thiourea Ligands as Potential Leishmanicidal Agents (2024)
Borges, Alice Prudente; Obata, Malu Mateus Santos; Libardi, Silvia H. ; Trevisan, Rafael O.; Deflon, Victor Marcelo ; Abram, Ulrich ; Ferreira, Francis B.; Costa, Luiz Antônio S.; Patrocínio, Antonio Otavio de Toledo ; Silva, Marcos V. da; Borges, Julio Cesar ; Maia, Pedro Ivo da Silva
Source: Pharmaceutics. Unidade: IQSC
Subjects: SULFONAMIDAS, OURO, PRATA, LEISHMANIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BORGES, Alice Prudente et al. Gold(I) and Silver(I) Complexes Containing Hybrid Sulfonamide/Thiourea Ligands as Potential Leishmanicidal Agents. Pharmaceutics, v. 16, p. 452, 2024Tradução . . Disponível em: https://doi.org/10.3390/pharmaceutics16040452. Acesso em: 08 out. 2025.
APA
Borges, A. P., Obata, M. M. S., Libardi, S. H., Trevisan, R. O., Deflon, V. M., Abram, U., et al. (2024). Gold(I) and Silver(I) Complexes Containing Hybrid Sulfonamide/Thiourea Ligands as Potential Leishmanicidal Agents. Pharmaceutics, 16, 452. doi:10.3390/pharmaceutics16040452
NLM
Borges AP, Obata MMS, Libardi SH, Trevisan RO, Deflon VM, Abram U, Ferreira FB, Costa LAS, Patrocínio AO de T, Silva MV da, Borges JC, Maia PI da S. Gold(I) and Silver(I) Complexes Containing Hybrid Sulfonamide/Thiourea Ligands as Potential Leishmanicidal Agents [Internet]. Pharmaceutics. 2024 ;16 452.[citado 2025 out. 08 ] Available from: https://doi.org/10.3390/pharmaceutics16040452
Vancouver
Borges AP, Obata MMS, Libardi SH, Trevisan RO, Deflon VM, Abram U, Ferreira FB, Costa LAS, Patrocínio AO de T, Silva MV da, Borges JC, Maia PI da S. Gold(I) and Silver(I) Complexes Containing Hybrid Sulfonamide/Thiourea Ligands as Potential Leishmanicidal Agents [Internet]. Pharmaceutics. 2024 ;16 452.[citado 2025 out. 08 ] Available from: https://doi.org/10.3390/pharmaceutics16040452
Artigo de periodico
Polylactide nanocapsules attenuate adverse cardiac cellular effects of Lyso-7, a Pan-PPAR agonist/anti-inflammatory new thiazolidinedione (2021)
Garcia, Giani Martins; Roy, Jérôme; Pitta, Ivan R; Abdalla, Dulcinéia Saes Parra ; Guimarães, Andrea Grabe ; Mosqueira, Vanessa Carla Furtado ; Richard, Sylvain
Source: Pharmaceutics. Unidade: FCF
Subjects: NANOPARTÍCULAS, ARTERIOSCLEROSE, SÍNDROME X METABÓLICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GARCIA, Giani Martins et al. Polylactide nanocapsules attenuate adverse cardiac cellular effects of Lyso-7, a Pan-PPAR agonist/anti-inflammatory new thiazolidinedione. Pharmaceutics, v. 13, p. 1-13 art. 1521, 2021Tradução . . Disponível em: https://doi.org/10.3390/pharmaceutics13091521. Acesso em: 08 out. 2025.
APA
Garcia, G. M., Roy, J., Pitta, I. R., Abdalla, D. S. P., Guimarães, A. G., Mosqueira, V. C. F., & Richard, S. (2021). Polylactide nanocapsules attenuate adverse cardiac cellular effects of Lyso-7, a Pan-PPAR agonist/anti-inflammatory new thiazolidinedione. Pharmaceutics, 13, 1-13 art. 1521. doi:10.3390/pharmaceutics13091521
NLM
Garcia GM, Roy J, Pitta IR, Abdalla DSP, Guimarães AG, Mosqueira VCF, Richard S. Polylactide nanocapsules attenuate adverse cardiac cellular effects of Lyso-7, a Pan-PPAR agonist/anti-inflammatory new thiazolidinedione [Internet]. Pharmaceutics. 2021 ; 13 1-13 art. 1521.[citado 2025 out. 08 ] Available from: https://doi.org/10.3390/pharmaceutics13091521
Vancouver
Garcia GM, Roy J, Pitta IR, Abdalla DSP, Guimarães AG, Mosqueira VCF, Richard S. Polylactide nanocapsules attenuate adverse cardiac cellular effects of Lyso-7, a Pan-PPAR agonist/anti-inflammatory new thiazolidinedione [Internet]. Pharmaceutics. 2021 ; 13 1-13 art. 1521.[citado 2025 out. 08 ] Available from: https://doi.org/10.3390/pharmaceutics13091521

USP Schools

ReP

Filtros

Authors

Subjects

Funding Agencies

Non normalized affiliation